(Q35584752)

9 August 2017

An observational study of bevacizumab-induced hypertension as a clinical biomarker of antitumor activity (English)

1 reference

9 August 2017

0 references

1 reference

1 reference

8

Jean-Marc Treluyer

0 references

0 references

2

Romain Coriat

1 reference

9 August 2017

Olivier Mir

1

1 reference

9 August 2017

Laure Cabanes

3

1 reference

9 August 2017

Stanislas Ropert

4

1 reference

9 August 2017

Bertrand Billemont

5

1 reference

9 August 2017

Jérôme Alexandre

6

1 reference

9 August 2017

Jean-Philippe Durand

7

1 reference

9 August 2017

Jean-Marc Treluyer

8

1 reference

9 August 2017

Bertrand Knebelmann

9

1 reference

9 August 2017

François Goldwasser

10

1 reference

9 August 2017

1 August 2011

1 reference

9 August 2017

1 reference

9 August 2017

16

1 reference

9 August 2017

9

1 reference

9 August 2017

1325-1332

1 reference

Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment

9 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228164

Management of hypertension in angiogenesis inhibitor-treated patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228164

Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228164

Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228164

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228164

Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228164

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228164

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228164

Reporting results of cancer treatment

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228164

Hypertension as a surrogate marker for the activity of anti-VEGF agents.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228164

Could rigorous diagnosis and management of hypertension reduce cardiac events in patients with renal cell carcinoma treated with tyrosine kinase inhibitors?

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228164

Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228164

Home blood-pressure monitoring in patients receiving sunitinib

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228164

Practice Guidelines For Primary Care Physicians

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21807768

12 December 2020

inferred from PubMed ID database lookup

Hypertension as a predictive factor of Sunitinib activity

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21807768

12 December 2020

inferred from PubMed ID database lookup

Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21807768

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1634/THEONCOLOGIST.2010-0002

1 reference

release_x7b56sfopzep3a2cwkpzv5iiba

9 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/x7b56sfopzep3a2cwkpzv5iiba

24 November 2022

mapped directly with Wikidata item

PMCID

3228164

1 reference

9 August 2017

1 reference